Clinical Site

Madrid 28222

2 studies enrolling now · 8 studies all time

What they study most

Arthritis, Psoriatic, C3 Glomerulopathy (C3G), Celiac Disease, Hidradenitis Suppurativa, In-situ Small Bowel T-cell Lymphoma, Type II Refractory Celiac Disease (RCD-II)

Studies at this site

• Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response — Recruiting now
• Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug — Running, not enrolling
• A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa — Enrolling by invitation
• Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
• PRV-015 in Gluten-free Diet Non-responsive Celiac Disease — Completed
• Controlled Trial Evaluating Avacopan in C3 Glomerulopathy — Completed
• Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis — Completed
• Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease — Completed